NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1020210066

Registered date:28/01/2022

Nicotinamide Adenine Dinucleotide Homeostasis in Cancer Patients

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedcancer
Date of first enrollment01/12/2021
Target sample size100
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeNicotinamide adenine dinucleotide levels at the time of the first visit to our department, at the time of admission for surgery, the day after surgery, and about one week after surgery
Secondary OutcomeCorrelation between nicotinamide adenine dinucleotide levels and clinical factors

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteriaPatients undergoing cancer treatment at Hirosaki university hospital from Dec. 2021. Subjects must meet the following criteria to be enrolled in this study. 1. Age >20 years. 2. Patients who have been fully informed about the participation in this study and have given written consent of their own free will with full understanding.
Exclude criteriaPatients who are judged by the principal investigator to be unsuitable as subjects.

Related Information

Contact

Public contact
Name Keinosuke Ishido
Address 53 Honcho, Hirosaki, Aomori Aomori Japan 036-8563
Telephone +81-172395079
E-mail wakiya1979@hirosaki-u.ac.jp
Affiliation Hirosaki University Hospital
Scientific contact
Name Kenichi Hakamada
Address 53 Honcho, Hirosaki, Aomori Aomori Japan 036-8562
Telephone +81-172395079
E-mail hakamada@hirosaki-u.ac.jp
Affiliation Hirosaki University Hospital